Table 3.
Variable | Persistencec OR (95% CI) | p-value | Mortalityd OR (95% CI) | p-value |
---|---|---|---|---|
72h IL-10/TNF ratioa | 2.98 (1.39 − 6.39) | 0.005 | 9.87 (2.64 − 36.91) | <0.001 |
Source risk categoryb | ||||
High vs. Low Risk | 0.83 (0.27 − 2.59) | 0.64 | 0.62 (0.12 − 3.12) | 0.91 |
Intermediate vs. Low | 1.08 (0.41 − 2.87) | 0.67 | 0.32 (0.07 − 1.56) | 0.17 |
Age | 1.01 (0.98 − 1.03) | 0.68 | 1.02 (0.98 − 1.07) | 0.29 |
Female | 1.22 (0.56 − 2.64) | 0.62 | 3.09 (0.86 − 11.15) | 0.09 |
Immunosuppressed | 0.31 (0.06 − 1.54) | 0.15 | 0.76 (0.12 − 4.88) | 0.77 |
ICU admission | 2.87 (1.33 − 6.18) | <0.01 | 9.48 (2.39 − 37.62) | <0.01 |
Abbreviations: CI, confidence interval; IL, interleukin; TNF, tumor necrosis factor; OR, odds
ratio
IL 10/TNF ratio cutoff value used in model was 1.00 for persistence and 2.56 for mortality;
Based on mortality risk (low <10%: intravenous catheter, urinary tract, ear-nose- larynx, gynecologic sources, and manipulation-related sources, 10–20%: osteoarticular, soft-tissue, and unknown sources, >20%: endovascular, lower respiratory tract, and abdominal sources, and CNS foci) (5);
r2 = 0.19;
r2 = 0.42